Literature DB >> 29685936

Letter by Clerkin et al Regarding Article, "Importance of Routine Antihuman/Leukocyte Antibody Monitoring: De Novo Donor Specific Antibodies Are Associated With Rejection and Allograft Vasculopathy After Heart Transplantation".

Kevin J Clerkin1, Maryjane A Farr1, Donna M Mancini2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29685936      PMCID： PMC6005392          DOI： 10.1161/CIRCULATIONAHA.117.032072

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  5 in total

Review 1.  Allograft coronary artery disease: clinical correlations with circulating anti-HLA antibodies and the immunohistopathologic pattern of vascular rejection.

Authors:  D O Taylor; R L Yowell; A G Kfoury; E H Hammond; D G Renlund
Journal:  J Heart Lung Transplant       Date:  2000-06       Impact factor: 10.247

2.  Pre- and posttransplantation allosensitization in heart allograft recipients: major impact of de novo alloantibody production on allograft survival.

Authors:  Eric K Ho; George Vlad; Elena Rodica Vasilescu; Ludwika de la Torre; Adriana I Colovai; Elizabeth Burke; Mario Deng; Joseph Schwartz; Charles Marboe; Donna Mancini; Gerhard Opelz; Nicole Suciu-Foca
Journal:  Hum Immunol       Date:  2010-11-10       Impact factor: 2.850

3.  Importance of Routine Antihuman/Leukocyte Antibody Monitoring: De Novo Donor Specific Antibodies Are Associated With Rejection and Allograft Vasculopathy After Heart Transplantation.

Authors:  Ka L Wong; Timucin Taner; Byron H Smith; Sudhir S Kushwaha; Brooks S Edwards; Manish J Gandhi; Walter K Kremers; Richard C Daly; Naveen L Pereira
Journal:  Circulation       Date:  2017-10-03       Impact factor: 29.690

4.  De novo donor HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival.

Authors:  J D Smith; N R Banner; I M Hamour; M Ozawa; A Goh; D Robinson; P I Terasaki; M L Rose
Journal:  Am J Transplant       Date:  2011-01-10       Impact factor: 8.086

5.  Donor-specific anti-HLA antibodies with antibody-mediated rejection and long-term outcomes following heart transplantation.

Authors:  Kevin J Clerkin; Maryjane A Farr; Susan W Restaino; Emmanuel Zorn; Farhana Latif; Elena R Vasilescu; Charles C Marboe; Paolo C Colombo; Donna M Mancini
Journal:  J Heart Lung Transplant       Date:  2016-11-17       Impact factor: 10.247
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.